- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03514797
Combined Dental Bleaching Protocols and Time Required to Achieve Satisfactory Color
April 17, 2019 updated by: André Luis Faria e Silva
Effect of a Single Prior Session of In-office Dental Bleaching on Time Required to Obtain Satisfactory Tooth Color With At-home Bleaching
This parallel, randomized, and controlled clinical trial will assess the effect of a single prior session of in-office dental bleaching on time required to achieve satisfactory tooth color with at-home bleaching.
Participants enrolled will randomly allocated to receive or not a single session of dental bleaching with 35% hydrogen peroxide applied for 45 min.
Following, all participants will use customized trays filled with 10% carbamide peroxide for 1h per day until obtain satisfactory results.
The primary outcome will be the number of days necessary to obtain satisfactory tooth color.
Furthermore, tooth sensitivity and color changes measured with spectrophotometer will be assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SE
-
Aracaju, SE, Brazil, 49060100
- Universidade Federal de Sergipe
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Good general and oral health;
- Upper canines darker than the tab 2.5M2 at VITA Bleachedguide 3D-MASTER® (Vita-Zahnfabrik, Bad Sackingen, Germany) scale.
Exclusion Criteria:
- Presence of non-treated caries or periodontal disease;
- Prior tooth hypersensitivity;
- Presence of gingival recession;
- Teeth with cracked enamel or any hypoplasia;
- Patients using oral removable or fixed orthodontic appliances;
- Patients were pregnant or breastfeeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined technique
A single session of in-office tooth bleaching will be performed with 35% hydrogen peroxide for 45 minutes.
Following, the teeth will be further bleached with customized trays filled with 10% carbamide peroxide and used for 1h per day.
|
In-office tooth bleaching with 35% hydrogen peroxide in a single application of 45 minutes.
At-home tooth bleaching with 10% carbamide peroxide for 1 hour per day.
|
|
Active Comparator: At-home bleaching
The teeth will be bleached only with customized trays filled with 10% carbamide peroxide and used for 1h per day.
|
In-office tooth bleaching with 35% hydrogen peroxide in a single application of 45 minutes.
At-home tooth bleaching with 10% carbamide peroxide for 1 hour per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to tooth color satisfaction
Time Frame: up to 1 month after beginning the tooth bleaching procedures
|
Time in days performing at-home bleaching necessary to participant reports that is satisfied with the tooth color obtained
|
up to 1 month after beginning the tooth bleaching procedures
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Color change
Time Frame: up to 1 month after beginning the tooth bleaching procedures
|
Values of delta E measured with a spectrophotometer from color at baseline
|
up to 1 month after beginning the tooth bleaching procedures
|
|
Tooth sensitivity
Time Frame: 1, 2, 3, and 4 week after beginning the tooth bleaching procedures
|
Maximum level of tooth sensitivity reported by participants using an analogue visual scale.
The distance between the patient's marking and the no pain border was recorded in cm.
|
1, 2, 3, and 4 week after beginning the tooth bleaching procedures
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cardoso PC, Reis A, Loguercio A, Vieira LC, Baratieri LN. Clinical effectiveness and tooth sensitivity associated with different bleaching times for a 10 percent carbamide peroxide gel. J Am Dent Assoc. 2010 Oct;141(10):1213-20. doi: 10.14219/jada.archive.2010.0048.
- Rezende M, Ferri L, Kossatz S, Loguercio AD, Reis A. Combined Bleaching Technique Using Low and High Hydrogen Peroxide In-Office Bleaching Gel. Oper Dent. 2016 Jul-Aug;41(4):388-96. doi: 10.2341/15-266-C. Epub 2016 Feb 26.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 13, 2018
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
April 13, 2018
First Submitted That Met QC Criteria
May 1, 2018
First Posted (Actual)
May 2, 2018
Study Record Updates
Last Update Posted (Actual)
April 19, 2019
Last Update Submitted That Met QC Criteria
April 17, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Combined bleaching
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.